Avecia Biologics Overview

  • Founded
  • 2006
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 469
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Avecia Biologics General Information

Description

Developer and manufacturer of biotechnology-based medicines. The company is a contract manufacturing organization with specific expertise in microbial-derived biologics.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Merck Sharp & Dohme
Primary Office
  • PO Box 42
  • Manchester M31 4LR
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Avecia Biologics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Avecia Biologics‘s full profile, request access.

Request a free trial

Avecia Biologics Executive Team (1)

Name Title Board Seat Contact Info
Steve Bagshaw President
To view Avecia Biologics’s complete executive team members history, request access »

Avecia Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avecia Biologics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Avecia Biologics‘s full profile, request access.

Request a free trial